Page last updated: 2024-10-26

diphenyleneiodonium and Leukemia, Myeloid, Acute

diphenyleneiodonium has been researched along with Leukemia, Myeloid, Acute in 1 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mondet, J1
Presti, CL1
Garrel, C1
Skaare, K1
Mariette, C1
Carras, S1
Park, S1
Carré, M1
Bulabois, CE1
Molina, L1
Gressin, R1
Thiebaut, A1
Courby, S1
Socoro-Yuste, N1
Faure, P1
Leer-Florin, AM1
Cahn, JY1
Mossuz, P1

Other Studies

1 other study available for diphenyleneiodonium and Leukemia, Myeloid, Acute

ArticleYear
Adult patients with
    Haematologica, 2019, Volume: 104, Issue:9

    Topics: Adult; Aged; Antimycin A; Antioxidants; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Ac

2019